Del Sette Capital Management LLC Invests $1.25 Million in DaVita Inc. (NYSE:DVA)

Del Sette Capital Management LLC acquired a new stake in shares of DaVita Inc. (NYSE:DVA) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 8,386 shares of the company’s stock, valued at approximately $1,254,000. DaVita accounts for approximately 1.0% of Del Sette Capital Management LLC’s portfolio, making the stock its 25th biggest position.

Several other institutional investors have also recently made changes to their positions in the business. Franklin Resources Inc. lifted its stake in DaVita by 134.6% in the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC boosted its position in DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares in the last quarter. Atom Investors LP purchased a new position in DaVita in the third quarter valued at about $4,094,000. Assenagon Asset Management S.A. lifted its position in DaVita by 201.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after acquiring an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in shares of DaVita during the 3rd quarter valued at $726,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Down 0.5 %

Shares of DVA stock opened at $148.25 on Friday. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $125.64 and a twelve month high of $179.60. The stock has a 50 day moving average of $158.53 and a 200 day moving average of $157.51. The stock has a market cap of $11.86 billion, a P/E ratio of 13.80, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Cowen reissued a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Barclays lifted their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, StockNews.com downgraded DaVita from a “buy” rating to a “hold” rating in a report on Friday. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.